Evidence for pathogenic involvement of eosinophils and neutrophils in Churg-Strauss syndrome

Journal of the American Academy of Dermatology

Volumn 47, Issue 2, 2002, Pages 209-216

  Drage, Lisa A ^a   Davis, Mark D P ^a   De Castro, Fernando ^a   Van Keulen, Virginia ^a   Weiss, Ellen A ^a   Gleich, Gerald J ^a   Leiferman, Kristin M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EOSINOPHIL PROTEIN X; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; LEUKOCYTE ELASTASE; MAJOR BASIC PROTEIN;

ADULT; AGED; ARTICLE; BLISTER; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOLOGY; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; SERUM; SKIN BIOPSY; SKIN DISEASE; CASE REPORT; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN;

ADULT; CHURG-STRAUSS SYNDROME; EOSINOPHILS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUTROPHILS; SKIN;

EID: 0036667329     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.124600     Document Type: Article

References (44)

1. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951;27:277-301.
2. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1984;63:65-81.
3. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
4. Gayraud M, Guillevin L, Le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001;44:666-75.
5. Solans R, Bosch JA, Pérez-Bocanegra C, Selva A, Huguet P, Alijotas J, et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology 2001;40:763-71.
6. Davis MD, Daoud MS, McEvoy MT, Su WP. Cutaneous manifestations of Churg-Strauss Syndrome: a clinicopathologic correlation. J Am Acad Dermatol 1997;32:199-203.
7. Gibson LE. Granulomatous vasculitides and the skin. Dermatol Clin 1990;8:335-45.
8. Crotty CP, DeRemee RA, Winkelman RK. Cutaneous clinicopathologic correlation of allergic granulomatosis. J Am Acad Dermatol 1981;5:571-81.
9. Horie S, Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J Immunol 1994;152:5457-67.
10. Ohnishi T, Kita H, Weiler D, Sur S, Sedgwick JB, Calhoun WJ, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993;147:901-7.
11. Abrams JS, Roncarlo MG, Yssel H, Anderson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992;127:5-24.
12. Limaye AP, Abrams JS, Silver JE, Ottesen EA, Nutman TB. Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med 1990;172:399-402.
13. Rotman B, Papermaster BW. Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc Natl Acad Sci U S A 1966;55:134-41.
14. Pullen GR, Chalmers PJ, Nind AP, Nairn RC. Criteria of cell killing in vitro. J Immunol Methods 1981;43:87-93.
15. Ott NL, Gleich GJ, Peterson EA, Fujisawa T, Sur S, Leiferman KM. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. J Allergy Clin Immunol 1994;94:120-8.
16. Wagner JM, Bartemes K, Vernof KK, Dunnette S, Offord KP, Checkel JL, et al. Analysis of pregnancy-associated major basic protein levels throughout gestation. Placenta 1993;14:671-81.
17. Maddox DE, Butterfield JH, Ackerman SJ, Coulam CB, Gleich GJ. Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein. J Exp Med 1983;158:1211-26.
18. Abu-Ghazaleh RI, Dunnette SL, Loegering DA, Checkel JL, Kita H, Thomas LL, et al. Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol 1992;52:611-8.
19. Perez GP, Peters MS, Reda AM, Butterfield JH, Peterson EA, Leiferman KM. Mast cells, eosinophils and neutrophils in prurigo nodularis. Arch Dermatol 1993;129:861-6.
20. Johnson MW, Bienenstock J. Abolition of non-specific fluorescent staining of eosinophils. J Immunol Methods 1974;2:189-94.
21. Gleich GJ, Adolphson CR, Leiferman KM. Eosinophils. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation, basic principles and clinical correlates. New York: Raven Press; 1992. p. 663-700.
22. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-63.
23. Sur S, Glitz DG, Kita H, Kujawa SM, Peterson EA, Weiler DA, et al. Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes. J Leukoc Biol 1998; 63:715-22.
24. Leiferman KM. Eosinophils, interleukin-5, and cutaneous disease. In: Sanderson CJ, editor. Interleukin-5: from molecule to drug target for asthma. Lung Biology in Health and Disease. New York: Marcel Dekker, Inc; 1999. p. 95-118.
25. Cheng JF, Ott NL, Peterson EA, George TJ, Hukee M, Gleich GJ, et al. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J Allergy Clin Immunol 1997;99:683-92.
26. Peen E, Hahn P, Lauwers G, Williams RC Jr, Gleich G, Kephart GM. Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues. Arthritis Rheum 2000;43:1897-900.
27. Termeer CC, Simon JC, Schöpf E. Low-dose interferon alfa-2b for the treatment of Churg-Strauss syndrome with prominent skin involvement. Arch Dermatol 2001;137:136-8.
28. Janoff A. Elastase in tissue injury. Annu Rev Med 1985;36:207-16.
29. Chen K-R, Pittelkow MR, Su WPD, Gleich GJ, Newman W, Leiferman KM. Recurrent cutaneous necrotizing eosinophilic vasculitis: a novel eosinophil mediated syndrome. Arch Dermatol 1994; 130:1159-66.
30. Chen K-R, Su WPD, Pittelkow MR, Conn DL, George T, Leiferman KM. Eosinophilic vasculitis in connective tissue disease. J Am Acad Dermatol 1996;35:173-82.
31. Leiferman KM, Peters MS, Gleich GJ. The eosinophil and cutaneous edema. J Am Acad Dermatol 1986;15:513-7.
32. Scheman AJ, Hordinsky MD, Groth DW, Vercellotti GM, Leiferman KM. Evidence for eosinophil degranulation in the pathogenesis of herpes gestationis. Arch Dermatol 1989;125:1079-83.
33. Thyresson NH, Goldberg NC, Tye MJ, Leiferman KM. Localization of eosinophil granule major basic protein in incontinentia pigmenti. Pediatr Dermatol 1991;8:102-6.
34. Daoud MS, Su WPD, Leiferman KM, Perniciaro C. Bullous morphea: clinical, pathologic and immunopathologic evaluation of thirteen cases. J Am Acad Dermatol 1994;30:937-43.
35. Davis MDP, Perniciaro C, Dahl PR, Randle HW, McEvoy MT, Leiferman KM. Exaggerated arthropod-bite lesions in patients with chronic lymphocytic leukemia: a clinical, histopathologic and immunopathologic study of eight patients. J Am Acad Dermatol 1998;39:27-35.
36. Borrego L, Maynard B, Peterson EA, George T, Iglesias L, Peters MS, et al. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid: comparison with neutrophil and mast cell granule proteins. Am J Pathol 1996;148: 897-909.
37. Czech W, Schaller J, Schopf E, Kapp A. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris. J Am Acad Dermatol 1993;29: 210-5.
38. Stahle-Backdahl M, Inoue M, Giudice GJ, Parks WC. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest 1994;93:2022-30.
39. Minnicozzi M, Duran WN, Gleich GJ, Egan RW. Eosinophil granule proteins increase microvascular transport in the hamster cheek pouch. J Immunol 1994;153:2664-70.
40. O'Donnell MC, Ackerman SJ, Gleich GJ, Thomas LL. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med 1983;157:1981-91.
41. Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O'Connell EJ, Kohler PF. Episodic angioedema associated with eosinophilia. N Engl J Med 1984;310:1621-6.
42. Leiferman KM, Loegering DL, Gleich GJ. Production of whealand-flare skin reactions by eosinophil granule proteins [abstract]. J Invest Dermatol 1984;82:414.
43. van Haelst-Pisani C, Kovach JS, Kita H, Leiferman KM, Gleich GJ, Silver JE, et al. Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer. Blood 1991;78:1538-44.
44. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997;17:519-28.